Superworth

CorMedix price to free cash flow CRMD

Market value divided by free cash flow over the last twelve months, since 2025.

Today, Nov 2, 2026
1.7×
Peer median
11.7×

CorMedix's price to free cash flow is 1.7× as of Nov 2, 2026.

The median for 10 large drugmakers of a similar size is 11.7×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.7×1.7×12.9×
202513.3×10.2×36.4×

Against its peers

Companies in Drug Manufacturers - General nearest CorMedix's size, closest first, today.

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on CorMedix

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.